Gout patients are not recommended to take Febuxostat tablets for acute attacks. Febuxostat tablets is a kind of inhibitor of uric acid synthesis to reduce the concentration of blood uric acid in the body of xanthine oxidase inhibitors, generally used for long-term treatment of gout patients with hyperuricemia, because the drug can reduce the concentration of blood uric acid, so in the acute attack of gout taking febuxostat can make the fluctuation of the concentration of blood uric acid and aggravate the gout of acute attacks. Therefore, gout patients should not take Febuxostat before the clinical symptoms such as joint swelling and pain are stabilized, but if an acute attack of gout occurs during the course of taking Febuxostat, the dosage of Febuxostat can be changed and the treatment can be continued. Common adverse reactions include hepatic impairment, nausea, arthralgia and rash. It is contraindicated in patients with a history of hypersensitivity to the components of the product and in patients receiving azathioprine or mercaptopurine therapy. Take care to monitor liver and kidney function and blood picture during administration. Febuxostat should be used under the guidance of a physician, and gout patients are advised to go to the rheumatology and immunology department of a regular hospital for detailed consultation and treatment in accordance with medical advice.